阻断PlGF或VEGF与NRP1受体相互作用的抗体介导抗增殖效应
Samuel A Blackman1, Ahlam N Qerqez1, Alison G Lee2
1McKetta Department of Chemical Engineering, The University of Texas at Austin, 200 E Dean Keeton St, Austin, TX 78712.
bioRxiv : the preprint server for biology
|November 27, 2025
概括
针对血管内皮生长因子A (VEGFA) 和胎盘生长因子2 (PlGF-2) 与神经皮林受体1 (NRP1) 相互作用的新抗体显示出克服瘤耐药性和抑制癌细胞增殖的希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 血管内皮生长因子A (VEGFA) 抑制剂是有前途的癌症疗法,但瘤耐药性限制了疗效.
- 抗药性可能来自于胎盘生长因子2 (PlGF-2) 的升高调节,它也结合VEGF受体1 (VEGFR1) 和神经素受体1 (NRP1).
- 了解VEGFA和PlGF-2与受体和细胞外基质的复杂相互作用,对于开发有效疗法至关重要.
研究的目的:
- 开发新型抗体,阻止VEGFA/PlGF-2及其共享受体NRP1.1之间的相互作用.
- 研究这些抗体影响血管生成和癌细胞增殖的机制.
- 探索针对VEGFA和PlGF-2的双反应性抗体策略,以克服耐药性.
主要方法:
- 发现了针对VEGFA/PlGF-2与NRP1相互作用的抗体,在存在肝素时.
- 在血管生成模型中对人类静脉内皮细胞 (HUVEC) 管形成对抗VEGFA抗体影响的评估.
- 在Caki-I癌细胞增殖过程中,对阻断PlGF-2或VEGFA与NRP1结合的抗体进行试验.
- 一种双反应性抗体的表征,该抗体可以结合VEGFA和PlGF-2.
主要成果:
- 阻断VEGFR1和NRP1相互作用的抗VEGFA抗体减少了HUVEC管的形成,表明血管正常化.
- 阻断VEGFA或PlGF-2与NRP1结合的抗体显著抑制了Caki-I癌细胞的增殖.
- 发现了一种针对VEGFA和PlGF-2的新型双反应性抗体.
- 这些发现突显了NRP1在癌细胞增殖中除了血管生成之外的作用.
结论:
- 针对VEGFA和PlGF-2与NRP1相互作用的新型抗体提供了新的治疗策略.
- 阻止VEGFA/PlGF-2-NRP1相互作用可以抑制瘤细胞的增殖,并可能克服抵抗机制.
- 双向抗体是对抗VEGFA和PlGF驱动的瘤生长的一种有希望的方法.
关键词:
在NRP1中,NRP1是指NRP1.美国PlGFF在VEGFA中,VEGFA是VEGFA.这就是VEGFR1的原因.血管新生是因为血管新生.抗体是对抗体的重要组成部分.肝素是一种肝素.菌体显示器可以显示菌体.更多相关视频
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.7K
10:24Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
10.7K
相关概念视频
02:38Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
01:24Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
01:16TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K